| Market Cap | €118.0M | |
| Enterprise Value | €49.7M | |
| Revenue | €848.2M | −7.0% |
| Gross Profit | €144.8M | +1.7% |
| EBITDA | €9.9M | — |
| Net Income | -€211.2M | — |
| Diluted EPS | -€2.23 | — |
| Free Cash Flow | €50.0M | +235.6% |
| DPS (FY2025) | €0.00derived |
| Trailing yield | 0.00% |
| Payout ratio | — |
| Growth streak | 0 yrs |
| 5y DPS growth | — |
| Fiscal year | DPS | YoY | Basis |
|---|---|---|---|
| FY20252025-12-31 | €0.00 | — | derived (paid ÷ diluted shares) |
| FY20242024-12-31 | €0.00 | — | derived (paid ÷ diluted shares) |
| FY20232023-12-31 | €0.00 | — | derived (paid ÷ diluted shares) |
| FY20222022-12-31 |
| Ratio | 2022 | 2023 | 2024 | 2025 | Trend · 4y | vs own |
|---|---|---|---|---|---|---|
| ▾Margins | ||||||
| Gross Margin | 17.67% | 15.68% | 14.82% | 16.56% | 63% | |
| Operating Margin | −0.08% | −23.12% | −13.20% | −15.40% | 38% | |
| EBITDA Margin | — | 6.77% | −4.78% | 1.17% | 50% | |
| NOPAT Margin | 0.00% | −18.27% | −10.43% | −12.16% | 38% | |
| Net Margin | −1.54% | −18.72% | −14.32% | −24.90% | 13% | |
| FCF Margin | −12.55% | −12.60% | 1.63% | 5.89% | 88% | |
| FCFF Margin | −12.55% | — | — | — | — | — |
| OCF Margin | 4.59% | 0.50% | 13.48% | 15.15% | 88% | |
| Gross Profitability | 10.19% | 10.21% | 9.56% | 11.10% | 88% | |
| Capex Intensity | 17.14% | 13.11% | 11.84% | 9.25% | 13% | |
| ▸Returns on Capital · 5 ratios | ||||||
| ▸DuPont factors (ROE drivers) · 3 ratios | ||||||
| ▸Earnings quality · 4 ratios | ||||||
| ▸Liquidity & coverage · 9 ratios | ||||||
| ▸Leverage · 7 ratios | ||||||
| ▸Working capital · 8 ratios | ||||||
| ▸Capital allocation · 4 ratios | ||||||
| ▸Per share · 3 ratios | ||||||
| ▸Other · 1 ratios | ||||||
| Line | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | €976.6M | €1.01B | €911.9M | €848.2M |
| YoY % | +3.7% | -10.0% | -7.0% | |
| Cost of Revenue | €804.0M | €854.3M | €776.8M | €707.7M |
| YoY % | +6.3% | -9.1% | -8.9% | |
| Gross Profit | €176.9M | €164.6M | €142.4M | €144.8M |
| YoY % | -7.0% | -13.5% | +1.7% | |
| R&D Expense | €21.8M | €29.6M | €25.8M | €27.3M |
| YoY % | +35.8% | -12.8% | +5.8% | |
| SG&A Expense | €90.5M | €90.0M | €89.4M | €80.3M |
| YoY % | -0.6% | -0.7% | -10.2% | |
| Operating Income | -€800,000 | -€234.3M | -€120.4M | -€130.6M |
| Interest Expense | €4.2M | €10.9M | €28.1M | €11.7M |
| YoY % | +159.5% | +157.8% | -58.4% | |
| Interest & Investment Income | €8.2M | €2.5M | €9.0M | €4.2M |
| YoY % | -69.5% | +260.0% | -53.3% | |
| Pretax Income | €3.1M | -€242.8M | -€139.6M | -€138.2M |
| Income Tax | €18.2M | -€53.0M | -€9.0M | €72.9M |
| Net Income (incl. NCI) | -€15.0M | -€189.7M | -€130.6M | -€211.2M |
| Minority Interest (P&L) | €0 | €0 | €0 | €0 |
| Net Income | -€15.0M | -€189.7M | -€130.6M | -€211.2M |
| Net Income to Common | -€15.0M | -€189.7M | — | — |
| EPS (Basic) | -€0.16 | -€2.02 | -€1.38 | -€2.23 |
| EPS (Diluted) | -€0.16 | -€2.02 | -€1.38 | -€2.23 |
| Weighted Avg Shares (Basic) | 93.7M | 94.2M | 94.5M | 94.7M |
| YoY % | +0.5% | +0.3% | +0.2% | |
| Weighted Avg Shares (Diluted) | 95.0M | 95.9M | 94.6M | 94.9M |
| YoY % | +0.9% | -1.4% | +0.3% |
Statement lines are XBRL facts as filed with the company's home regulator (SEC EDGAR for US filers; ESEF/EDINET and other national regulators for foreign filers); ratios and other derived figures are computed from them. A blank cell means the tag was absent — never imputed.
| €0.00 |
| — |
| derived (paid ÷ diluted shares) |
